Get the Stockscreener App
0.2649
1.16%
-0.0031
After Hours:
.26
-0.0049
-1.85%
cbdMD Inc stock is traded at $0.2649, with a volume of 458.14K.
It is down -1.16% in the last 24 hours and down -53.53% over the past month.
See More
Previous Close:
$0.268
Open:
$0.3098
24h Volume:
458.14K
Relative Volume:
0.24
Market Cap:
$1.66M
Revenue:
$23.45M
Net Income/Loss:
$-19.98M
P/E Ratio:
-0.021
EPS:
-12.63
Net Cash Flow:
$-2.65M
1W Performance:
-26.96%
1M Performance:
-53.53%
6M Performance:
-48.16%
1Y Performance:
-62.16%
1-Day Range:
$0.26
$0.3098
1-Week Range:
$0.232
$0.37
52-Week Range:
$0.232
$1.34
cbdMD Inc Stock (YCBD) Company Profile
Compare YCBD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
YCBD
cbdMD Inc
|
0.2649 | 1.66M | 23.45M | -19.98M | -2.65M | -12.63 |
|
ZTS
Zoetis Inc
|
160.06 | 71.67B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.03 | 47.44B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.19 | 46.08B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.46 | 18.86B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
131.36 | 13.97B | 612.78M | -86.37M | -62.91M | -0.87 |
cbdMD Inc Stock (YCBD) Latest News
cbdMD, Inc. to Host Earnings Call - ACCESS Newswire
cbdMD (NYSEAMERICAN:YCBD) Stock Price Up 1.5% – Time to Buy? - Defense World
cbdMD announces additional conversions of its convertible notes - MSN
cbdMD, Inc. (AMEX:YCBD) Q1 2025 Earnings Call Transcript - Insider Monkey
cbdMD Achieves Profitability, Highlights Growth in Earnings Call - TipRanks
cbdMD targets growth with new product launches and improved profitability in Q1 2025 - MSN
cbdMD Inc (YCBD) Q1 2025 Earnings Call Highlights: Achieving Profitability and Debt-Free Status By GuruFocus - Investing.com Canada
cbdMD, Inc. Reports Improved Earnings Amid Industry Challenges - TipRanks
cbdMD posts first-quarter profit despite lower sales - Green Market Report
cbdMD Generates $5.1 Million in Revenue, Positive Earnings - Yahoo Finance
cbdMD, Inc. to Host Conference Call to Discuss December 31, 2024 First Quarter of Fiscal Year 2025 Results - The Kingston Whig-Standard
cbdMD Earnings: Strategic Financial Review & Market Position Update Coming Feb 13 - StockTitan
cbdMD Inc [YCBD] is 54.03% higher this YTD. Is it still time to buy? - The DBT News
A Look at cbdMD Inc (YCBD) Shares in the Recent Past Indicates Growth - SETE News
cbdMD Inc (YCBD)’s highs and lows: A closer look at its stock price fluctuations - US Post News
YCBD’s Stock Market Adventure: 62.61% YTD Growth Amidst Volatility - The InvestChronicle
cbdMD Joins Forces with The Barstool Fund to Aid Small Businesses - cbdMD
Taking on analysts’ expectations and winning: cbdMD Inc (YCBD) - SETE News
CBD Hemp Oil Consumption Market Predicted at 17.97%CAGR to Cross 24.08 Billion USD by 2032 | Riot CBD, - EIN News
cbdMD Announces It Has Fully Satisfied Its Notes - The Kingston Whig-Standard
cbdMD Eliminates All Debt Through Early Note Conversion, Strengthens Financial Position - StockTitan
YCBDCbdmd Inc Latest Stock News & Market Updates - StockTitan
cbdMD Announces Additional Conversions of Its Convertible Notes - The Kingston Whig-Standard
cbdMD discloses NYSE listing compliance notice - MSN
cbdMD receives NYSE non-compliance notice - MSN
cbdMD Faces NYSE American Delisting Risk Over $2M Equity Requirement Shortfall - StockTitan
cbdMD (AMEX:YCBD) Stock Quotes, Forecast and News Summary - Benzinga
cbdMD Expands Board with CEO T. Ronan Kennedy - MSN
cbdMD Strengthens Leadership: CEO Kennedy Joins Board After Successful Business Turnaround - StockTitan
cbdMD posts lower annual sales, mixed fourth quarter - Green Market Report
cbdMD Inc. (YCBD) reports earnings - Quartz
cbdMD Slashes Losses by $19.1M Despite Sales Dip; Launches New Product Lines - StockTitan
cbdMD, Inc. to Host Conference Call to Discuss September 30, 2024 Fourth Quarter and Fiscal Year 2024 Results - The Kingston Whig-Standard
Dream Industrial REIT (DIR-UN-T) QuotePress Release - The Globe and Mail
cbdMD, Inc. Reschedules Earnings Release and Conference Call - Newsfile
S&P 500 Information Technology [Sector] (SRIT) QuotePress Release - The Globe and Mail
cbdMD, Inc. To Host Conference Call to Discuss September 30, 2024 Fourth Quarter and Fiscal Year 2024 Results - The Kingston Whig-Standard
YCBD Stock Touches 52-Week Low at $0.41 Amid Market Challenges - Investing.com
cbdMD Extends Lease on Executive Office and Warehouse By Investing.com - Investing.com Canada
cbdMD Extends Lease on Executive Office and Warehouse - Investing.com
CbdMD : Learn whether hemp cultivation and CBD production is truly sustainable by examining factors like water usage, soil health, and carbon footprint. - Marketscreener.com
CbdMD Launches Herbal Oasis Social Tonics, Hemp-Derived THC Seltzers - Barchart
cbdMD Launches THC Seltzers in $4B Market Push with Fast-Acting Technology | YCBD Stock News - StockTitan
cbdMD Launches Herbal Oasis Social Tonics, Hemp-Derived THC Seltzers - Newsfile
CBD Life Sciences Inc. (CBDL) Applies for Beer & Liquor License to Sell CBD Wine - Quantisnow
YCBD stock touches 52-week low at $0.43 amid market challenges - Investing.com
cbdMD Launches Line of CBD Products with Wegmans Food Markets - Newsfile
CBD Life Sciences, Inc. (CBDL) Secures Breakthrough Walmart Marketplace Approval for 3000MG Pain Relief Cream, Setting the Stage for Unprecedented Growth - Quantisnow
cbdMD Inc Stock (YCBD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.77%
0.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):